Compare PBI & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBI | NVCR |
|---|---|---|
| Founded | 1920 | 2000 |
| Country | United States | Switzerland |
| Employees | 6600 | N/A |
| Industry | Office Equipment/Supplies/Services | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | N/A | 2015 |
| Metric | PBI | NVCR |
|---|---|---|
| Price | $17.59 | $15.06 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $13.00 | ★ $28.08 |
| AVG Volume (30 Days) | 1.7M | ★ 1.8M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.29% | N/A |
| EPS Growth | N/A | ★ 21.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $655,353,000.00 |
| Revenue This Year | N/A | $7.72 |
| Revenue Next Year | N/A | $6.74 |
| P/E Ratio | $13.24 | ★ N/A |
| Revenue Growth | N/A | ★ 8.28 |
| 52 Week Low | $8.95 | $9.82 |
| 52 Week High | $19.07 | $21.45 |
| Indicator | PBI | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 45.73 | 44.54 |
| Support Level | $16.69 | $14.85 |
| Resistance Level | $18.51 | $15.46 |
| Average True Range (ATR) | 0.63 | 1.12 |
| MACD | -0.12 | -0.16 |
| Stochastic Oscillator | 15.57 | 3.67 |
Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal work sharing discounts. It derives maximum revenue from SendTech Solutions.
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.